- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: A-623
Total 11457 results
-
Biruni UniversityRecruitingPeriodontitis | Periodontal Therapy | Biomarker | miRNA-223Turkey
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
BayerCompletedBone Metastases | Hormone Refractory Prostate Cancer
-
BayerCompletedProstate CancerUnited States
-
BayerCompletedNeoplasm MetastasisSweden, Norway
-
BayerCompletedNeoplasm Metastasis | Prostate CancerSweden, United Kingdom
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
BayerCompletedProstatic Neoplasms, Castration-ResistantBelgium
-
BayerNo longer availableProstatic NeoplasmsUnited States
-
AbbVieNot yet recruiting
-
Ferrer Internacional S.A.Not yet recruiting
-
Sirtsei Pharmaceuticals, Inc.Rho, Inc.RecruitingMajor Depressive DisorderUnited States
-
Dana-Farber Cancer InstituteBioMed Valley Discoveries, IncActive, not recruiting
-
Enanta Pharmaceuticals, IncCompleted
-
AmgenTerminatedAcute Myeloid LeukemiaUnited States, Australia, Germany
-
xCuresCancer CommonsAvailableExpanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesMelanoma | Head and Neck Cancer | Glioblastoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Bladder Cancer | Thyroid Cancer | ERK Mutation | MAPK Gene Mutation | KRAS Activating... and other conditionsUnited States
-
Aldeyra Therapeutics, Inc.CompletedChronic CoughUnited States
-
Aldeyra Therapeutics, Inc.Completed
-
Seikagaku CorporationChiltern International Inc.Completed
-
Radboud University Medical CenterBayerCompletedBone Metastases | Castrate Resistant Prostate CancerNetherlands
-
Hutchison Medipharma LimitedUnknownImmune Thrombocytopenia (ITP)China
-
Asahi Kasei Pharma CorporationCompletedPostoperative Stage II/III Colon CancerJapan
-
BayerCompletedBone Metastatic Castration-resistant Prostate CancerGermany, Netherlands, Denmark
-
BayerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Bausch Health Americas, Inc.Completed
-
PfizerActive, not recruitingLymphoma | Multiple MyelomaJapan
-
Neurocrine BiosciencesCompletedMajor Depressive DisorderUnited States, Czechia, Bulgaria, Poland, Slovakia, Sweden
-
CytokineticsCompletedHealthy VolunteerJapan
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
BayerCompletedProstatic NeoplasmsChina, Singapore, Taiwan, Korea, Republic of
-
Johnson & Johnson Vision Care, Inc.Completed
-
National Cancer Institute (NCI)RecruitingClear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Collecting Duct Carcinoma | Kidney Medullary Carcinoma | Advanced Renal Cell Carcinoma | Unclassified Renal Cell CarcinomaUnited States
-
Coopervision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Duke UniversityBayerCompletedPharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate CancerBone Metastatic Castration-Resistant Prostate CancerUnited States
-
GE Healthcarei3 StatprobeCompletedParkinsonian SyndromesUnited States, France
-
Bausch & Lomb IncorporatedCompleted
-
BayerActive, not recruitingBone Metastatic Castration-resistant Prostate CancerFrance, Lithuania, Israel, Italy, United Kingdom, Austria
-
Hoffmann-La RocheCompleted
-
BayerActive, not recruitingProstatic Neoplasms, Castration-ResistantJapan
-
BayerCompletedNeoplasm Metastasis | Prostate CancerUnited Kingdom
-
BayerCompletedProstatic Neoplasms, Castration-ResistantGermany
-
Johnson & Johnson Vision Care, Inc.University of ManchesterCompleted
-
M.D. Anderson Cancer CenterBayerCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States